Sectors

KVUE
Kenvue Inc.
17.14
12500 x 17.11
19900 x 17.21
bid
ask
-
0.24
1.38%
16200 @ 04:00 PM
17.36 +0.22 (1.29%)
Ytd -0.64%
1y -28.19%
17.11
day range
17.44
14.11
52 week range
24.44
Open 17.36 Prev Close 17.38 Low 17.11 High 17.44 Mkt Cap 32.85B
Vol 13.13M Avg Vol 40.88M EPS 0.76 P/E 22.55 Forward P/E 14.17
Beta 0.47 Short Ratio 1.74 Inst. Own 96.08% Dividend 0.83 Div Yield 4.78
Ex Div Date 02-11 Earning 05-07 50-d Avg 17.98 200-d Avg 18.32 1yr Est 19.83
Earning
Date For Estimate Reported Surprise surprise %
2026-05-14 2026-03 0.27 N/A N/A N/A
2026-02-17 2025-12 0.22 0.27 0.05 22.73%
2025-11-03 2025-09 0.27 0.28 0.01 3.70%
2025-08-07 2025-06 0.28 0.29 0.01 3.57%
2025-05-08 2025-03 0.22 0.24 0.02 9.09%
2025-02-06 2024-12 0.26 0.26 N/A N/A
Upgrade / Downgrade
Date Firm Action From To
2026-03-06 Barclays Upgrade Equal-Weight Equal-Weight
2026-02-18 Canaccord Genuity Upgrade Hold Hold
2026-02-18 Citigroup Upgrade Neutral Neutral
2026-02-18 UBS Upgrade Neutral Neutral
2026-01-30 Jefferies Downgrade Buy Hold
2025-11-10 Barclays Upgrade Equal-Weight Equal-Weight
Profile
Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.
Insider Holder
Date Name Relation Quantity Description
2026-03-09 ALVARADO LUANI Chief Operating Officer 61.42K Conversion of Exercise of derivative security
2026-03-09 LAWSON CARLTON Officer 111.42K Conversion of Exercise of derivative security
2025-03-04 MONGON THIBAUT Chief Executive Officer 216.47K Conversion of Exercise of derivative security
2025-12-14 ORLANDO MATTHEW General Counsel 38.08K Conversion of Exercise of derivative security
2025-12-14 PERRY KIRK L Chief Executive Officer 62.55K Conversion of Exercise of derivative security
2025-03-04 RUH PAUL Chief Financial Officer 56.20K Conversion of Exercise of derivative security
Institution Ownership
Report Date Organization Position Value Percentage
2025-12-30 Vanguard Group Inc 234.95M 4.03B 12.26%
2025-12-30 Blackrock Inc. 159.55M 2.73B 8.32%
2025-12-30 State Street Corporation 118.87M 2.04B 6.20%
2025-12-30 FMR, LLC 94.11M 1.61B 4.91%
2025-12-30 Massachusetts Financial Services Co. 68.49M 1.17B 3.57%
2025-12-30 Pentwater Capital Management Lp 56.72M 972.19M 2.96%
Fund Ownership
Report Date Organization Position Value Percentage
2025-12-30 VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund 60.21M 1.03B 3.14%
2025-12-30 VANGUARD INDEX FUNDS-Vanguard 500 Index Fund 48.31M 827.99M 2.52%
2025-12-30 VANGUARD INDEX FUNDS-Vanguard Mid-Cap Index Fund 41.70M 714.72M 2.18%
2026-01-30 iShares Trust-iShares Core S&P 500 ETF 24.67M 422.82M 1.29%
2026-02-27 Fidelity Concord Street Trust-Fidelity 500 Index Fund 24.38M 417.89M 1.27%
2026-01-30 SPDR S&P 500 ETF TRUST-State Street SPDR S&P 500 ETF Trust 22.97M 393.63M 1.20%
Dividend
Dividend Date
0.2075 2026-02-11
0.2075 2025-11-12
0.2075 2025-08-13
0.205 2025-05-14
0.205 2025-02-12
0.205 2024-11-13